Language Select
Varian Logo

Press Releases

May 22, 2018
Varian (NYSE: VAR) today announced it received notice from Sirtex Medical Limited (Sirtex) on May 21, 2018 (Pacific daylight time) that the board of directors of Sirtex has now received a binding... Read more
May 17, 2018
Varian (NYSE: VAR) today announced it has signed a software technology training and education cooperation agreement with the Brazil Ministry of Health (MOH) and seven universities and science and... Read more
May 16, 2018
Varian (NYSE: VAR) announced two patients with brain cancer were the first patients in Korea to be treated using the company's HyperArc™ High Definition Radiotherapy (HDRT), a new type of... Read more
May 07, 2018
Varian (NYSE:VAR) today announced it has acquired Cooperative CL Enterprises (COOP), a leading distributor of radiotherapy equipment in Taiwan. COOP currently employs 45 people, and has... Read more
May 04, 2018
Varian (NYSE: VAR) today commented on the press release of Sirtex Medical Limited (Sirtex) dated May 4, 2018 announcing that Sirtex had received an unsolicited non-binding, indicative and... Read more
April 26, 2018
Varian (NYSE: VAR) today announced Hospital Alemão Oswaldo Cruz in São Paulo, Brazil will be the first hospital in Brazil to install a Halcyon™ treatment system. Scheduled to be installed in... Read more
April 25, 2018
Varian (NYSE: VAR) today announced it has signed an agreement with the Stockholm City Council to provide equipment and related services to the radiation therapy department of the New Karolinska... Read more
April 25, 2018
Second Quarter 2018 Summary Revenues of $730 million grew 10 percent, or 6 percent in constant currency Oncology gross orders grew 5 percent, or 1 percent in constant currency GAAP operating... Read more
April 20, 2018
Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Calypso® Anchored Beacon® transponder. Used with a Varian TrueBeam®, Edge® and Clinac® C-series medical linear... Read more
April 19, 2018
Varian (NYSE: VAR) today announced it will be showcasing the expanded imaging and treatment capabilities of the Halcyon™ system and the new version of the Velocity™ cancer imaging software,... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com

Monica Prokocki
Director, Investor Relations
650.424.5184
investors@varian.com